The latest news, trends, analysis, interviews and podcasts from the global food and beverage industry

Windfall Bio, a provider of methane-to-value solutions, has closed a $28 million Series A funding round led by Prelude Ventures. Notable participation came from Amazon’s Climate Pledge Fund, Global Brain (through its Norinchukin Innovation Fund L.P.), Incite Ventures and Positive Ventures. Existing investors, including B37 Ventures, Breakthrough Energy Ventures, Mayfield and Untitled (a fund backed by the Tetra Laval family), also contributed to the round. This influx of capital will support Windfall Bio in scaling its innovative methane capture and transformation solution, aimed at addressing methane emissions across various industries such as agriculture, oil and gas, and waste management. The funding will facilitate the expansion of pilot deployments and enable the company to grow its team, manufacturing capacity and supply chain to meet growing global demand for methane mitigation solutions. Methane contributes significantly to global warming. Windfall Bio’s nature-based solution offers a promising avenue for reducing methane emissions by capturing methane at a low cost while producing high-quality fertiliser onsite. This dual-purpose approach not only helps mitigate climate change but also generates additional value for customers. Josh Silverman, co-founder and CEO of Windfall Bio, said: “While addressing methane emissions is the most impactful strategy available today to tackle near-term climate change, it has remained a critically underappreciated and underfunded problem for global warming, only recently gaining significant attention in climate discussions”. He continued: “However, methane represents an important resource that can create significant value for customers if they are given the right tools. We’ve seen early commercial traction and with the support of our strategic investors, Windfall will empower customers across industries to eliminate harmful methane emissions and create valuable outputs in return.” Windfall Bio's solution uses methane-eating microbes to capture methane from any source and produce organic fertiliser onsite. This approach not only helps reduce emissions but also offers benefits such as improved soil health, emissions tracking and reporting, resource efficiency, and new revenue streams from the sale of organic fertiliser. Mark Cupta, managing director at Prelude Ventures, added: “Windfall Bio is a cost-effective and simple methane mitigation solution that increases the efficiency, profitability, and sustainability of methane emitting industries. Uniquely, Windfall’s approach can rapidly scale globally across large industries to meaningfully reduce methane emissions.” The successful Series A funding marks a significant milestone for Windfall Bio, following its $9 million seed raise in March 2023. The company's total fundraising now stands at $37 million, demonstrating strong support and validation for its methane mitigation solution. Founded in 2022 and headquartered in Menlo Park, California, Windfall Bio is backed by top-tier venture capital firms and aims to revolutionise methane mitigation across industries.